These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9506591)

  • 1. Use of procalcitonin as a diagnostic test: comment on the article by Eberhard et al.
    Espinosa-Morales R; Escalante A
    Arthritis Rheum; 1998 Mar; 41(3):567-8. PubMed ID: 9506591
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al.
    Moosig F; Reinhold-Keller E; Csernok E; Gross WL
    Arthritis Rheum; 1998 Mar; 41(3):566-7; author reply 568. PubMed ID: 9506590
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.
    Eberhard OK; Haubitz M; Brunkhorst FM; Kliem V; Koch KM; Brunkhorst R
    Arthritis Rheum; 1997 Jul; 40(7):1250-6. PubMed ID: 9214425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.
    Brunkhorst R; Eberhardt OK; Haubitz M; Brunkhorst FM
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S199-201. PubMed ID: 18470720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procalcitonin as a biomarker in patients with systemic lupus erythematosus].
    Consiglio FJ; Ordi Ros J
    Med Clin (Barc); 2013 Mar; 140(5):214-6. PubMed ID: 23276619
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma procalcitonin in rheumatic diseases].
    Scirè CA; Caporali R; Perotti C; Montecucco C
    Reumatismo; 2003; 55(2):113-8. PubMed ID: 12874646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.
    Serio I; Arnaud L; Mathian A; Hausfater P; Amoura Z
    Clin Rheumatol; 2014 Sep; 33(9):1209-15. PubMed ID: 25064130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum procalcitonin as a biomarker differentiating delayed-type drug hypersensitivity from systemic bacterial infection.
    Yoon SY; Baek SH; Kim S; Lee YS; Lee T; Bae YJ; Kwon HS; Huh JW; Hong SB; Cho YS; Chun S; Lim CM; Koh Y; Moon HB; Kim TB
    J Allergy Clin Immunol; 2013 Oct; 132(4):981-3. PubMed ID: 23768571
    [No Abstract]   [Full Text] [Related]  

  • 9. Can procalcitonin differentiate infection from systemic inflammatory reaction in patients on extracorporeal membrane oxygenation?
    Tanaka D; Pitcher HT; Cavarocchi NC; Diehl JT; Hirose H
    J Heart Lung Transplant; 2014 Nov; 33(11):1186-8. PubMed ID: 25260215
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment to "Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: the role of procalcitonin".
    Takahashi S
    Int J Urol; 2014 Jan; 21(1):107. PubMed ID: 23662997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Procalcitonin: a new diagnostic tool in bacterial infections].
    Name Bayona O; Fernández López A; Luaces Cubells C
    Med Clin (Barc); 2002 Nov; 119(18):706-14. PubMed ID: 12459110
    [No Abstract]   [Full Text] [Related]  

  • 12. [Procalcitonin bedside testing in the pediatric emergency department].
    Chalumeau M; Leroy S; Gendrel D; Bréart G; Moulin F; Dubos F
    Arch Pediatr; 2007 Jun; 14(6):529-31. PubMed ID: 17418544
    [No Abstract]   [Full Text] [Related]  

  • 13. Procalcitonin in intensive care units: the PRORATA trial.
    Landman GW; Kleefstra N
    Lancet; 2010 May; 375(9726):1606; author reply 1606-7. PubMed ID: 20452516
    [No Abstract]   [Full Text] [Related]  

  • 14. Procalcitonin in the elderly: normal plasma concentrations and response to bacterial infections.
    Dwolatzky T; Olshtain-Pops K; Yinnon AM; Raveh D; Rogowski O; Shapira I; Rotstein R; Berliner S; Rudensky B
    Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):763-5. PubMed ID: 16283216
    [No Abstract]   [Full Text] [Related]  

  • 15. A brief history of procalcitonin.
    Bohuon C
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S146-7. PubMed ID: 18470709
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE.
    Shin KC; Lee YJ; Kang SW; Baek HJ; Lee EB; Kim HA; Song YW
    Ann Rheum Dis; 2001 Oct; 60(10):988-9. PubMed ID: 11589181
    [No Abstract]   [Full Text] [Related]  

  • 17. Procalcitonin--a new indicator for bacterial infections.
    Steinbach G; Grünert A
    Exp Clin Endocrinol Diabetes; 1998; 106(3):164-7. PubMed ID: 9710354
    [No Abstract]   [Full Text] [Related]  

  • 18. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period.
    Oczenski W; Fitzgerald RD; Schwarz S
    Eur J Anaesthesiol; 1998 Mar; 15(2):202-9. PubMed ID: 9587727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of procalcitonin in the diagnosis of maternal-fetal infections].
    Petzold L; Guibourdenche J; Boissinot C; Benoist JF; Luton D; Demelier JF; Porquet D
    Ann Biol Clin (Paris); 1998; 56(5):599-602. PubMed ID: 9769506
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of procalcitonin in neonates at risk for infection.
    Martin-Denavit T; Monneret G; Labaune JM; Isaac C; Bienvenu F; Putet G; Bienvenu J
    Clin Chem; 1999 Mar; 45(3):440-1. PubMed ID: 10053059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.